Acadian Asset Management
ANAC

Acadian Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Acadian Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-145
Closed -$17K – 1628
2015
Q3 		$17K Sell
145
-26
-15% -$3.4K ﹤0.01% 1069
2015
Q2 		$14K Buy
+171
New +$11.2K ﹤0.01% 1123

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management's ANAC Position: Q4 2015 in Review

Acadian Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 145 shares — an estimated $17K sold.

Acadian Asset Management first reported a position in ANAC in Q2 2015 and held it in 2 quarters. The position peaked at $17K in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • Acadian Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • Acadian Asset Management sold 145 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $17K.
  • Acadian Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 2 quarters.
  • Acadian Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $17K in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Acadian Asset Management's 13F filing for Q4 2015, filed 14 Jan 2016.